← Eichor
Study identifier: NCT06815263 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Listener Training for Improved Intelligibility of People With Parkinson's Disease

Condition: Dysarthria, Hypokinetic  ·  Sponsor: Utah State University

PhaseNA
Planned participants360
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Listener training offers a promising avenue for improving communication for people with dysarthria due to Parkinson's disease by offsetting the intelligibility burden from the patient onto their primary communication partners. Here, we employ a repeated-measures, randomized controlled trial to establish the efficacy of listener training for patients with PD and their primary communication partners. This translational work will establish a new realm of clinical practice in which the intelligibility impairments in PD are addressed by training partners to better understand dysarthric speech, thus elevating communication outcomes and participation in daily life.

This description comes directly from the study's public registry record.

Talk to the study team

Morgan Robertson, PhD  ·  435-797-1388  ·  morgan.robertson@usu.edu

Stephanie Borrie, PhD  ·  435-797-1388  ·  stephanie.borrie@usu.edu

Always discuss trial participation with your own doctor first.

Locations (2)

Florida State UniversityTallahassee, Florida, United StatesRecruiting
Utah State UniversityLogan, Utah, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06815263